Evolent Health, Inc. (NYSE:EVH) Shares Sold by Rhumbline Advisers

Rhumbline Advisers lessened its stake in shares of Evolent Health, Inc. (NYSE:EVH) by 2.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 166,391 shares of the technology company’s stock after selling 3,749 shares during the quarter. Rhumbline Advisers’ holdings in Evolent Health were worth $1,872,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in EVH. Entropy Technologies LP lifted its holdings in Evolent Health by 247.6% in the fourth quarter. Entropy Technologies LP now owns 39,219 shares of the technology company’s stock valued at $441,000 after acquiring an additional 27,936 shares during the period. Tempus Wealth Planning LLC acquired a new stake in shares of Evolent Health during the 4th quarter worth about $240,000. Chicago Capital LLC raised its holdings in Evolent Health by 209.1% in the 4th quarter. Chicago Capital LLC now owns 31,134 shares of the technology company’s stock valued at $350,000 after acquiring an additional 21,061 shares during the last quarter. Chicago Partners Investment Group LLC lifted its position in Evolent Health by 50.0% during the fourth quarter. Chicago Partners Investment Group LLC now owns 13,643 shares of the technology company’s stock worth $153,000 after buying an additional 4,547 shares during the period. Finally, R Squared Ltd purchased a new stake in Evolent Health in the fourth quarter valued at approximately $31,000.

Evolent Health Stock Performance

Shares of EVH opened at $8.81 on Tuesday. Evolent Health, Inc. has a 52-week low of $8.40 and a 52-week high of $35.00. The firm has a market capitalization of $1.03 billion, a PE ratio of -10.74 and a beta of 1.45. The firm has a 50-day moving average price of $10.56 and a 200 day moving average price of $18.14. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.58.

Evolent Health (NYSE:EVH) last posted its quarterly earnings data on Thursday, February 20th. The technology company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.35). Evolent Health had a negative net margin of 2.41% and a positive return on equity of 5.73%. The business had revenue of $646.54 million for the quarter, compared to the consensus estimate of $650.92 million. On average, sell-side analysts anticipate that Evolent Health, Inc. will post 0.08 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Needham & Company LLC reissued a “buy” rating and set a $15.00 price target on shares of Evolent Health in a research report on Friday, February 21st. UBS Group cut their price objective on shares of Evolent Health from $27.00 to $14.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. JPMorgan Chase & Co. cut their price target on shares of Evolent Health from $15.00 to $13.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. BTIG Research lowered their price target on Evolent Health from $36.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. Finally, Truist Financial lowered their target price on Evolent Health from $20.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, January 22nd. One equities research analyst has rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $17.79.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.